EP3544601
A COMPOSITION COMPRISING A BENZAMIDE AND A TNFRSF AGONIST BINDING TO 4-1BB OR GITR, AND THE USE THEREOF IN THE TREATMENT OF CANCER.
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
24.11.2017EP published:
20.3.2024EP application number:
17875035.2
EPO information:
European Patent Register
Max expiry date:
23.11.2037
Title in English:
A COMPOSITION COMPRISING A BENZAMIDE AND A TNFRSF AGONIST BINDING TO 4-1BB OR GITR, AND THE USE THEREOF IN THE TREATMENT OF CANCER.Language of the patent:
English
Timeline
Today
24.11.2017EP application
20.3.2024EP Publication
Owner
Name:
Translational Drug Development, LLCAddress:
13208 East Shea Boulevard Suite 100, Scottsdale, Arizona 85259, US
Inventor
Name:
WANG, TongAddress:
Scottsdale, Arizona 85259, US
Name:
GATELY, StephenAddress:
Scottsdale, Arizona 85259, US
Name:
GONZALES, PaulAddress:
Scottsdale, Arizona 85259, US
Priority
Number:
201662426031 PDate:
23.11.2016Country:
US
Classification
Categories:
A61K 31/4184, A61K 31/166, A61K 31/4164, C07C 259/10, C07D 235/30, A61K 35/00, A61K 9/08